Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
Curtiss-Wright Corporation executive John C. Watts, EVP & Chief Growth Officer, reported a small share purchase under the company’s Employee Stock Purchase Plan (ESPP). On 01/05/2026, he acquired 13 shares of Curtiss-Wright common stock at a price of $472.17 per share, as shown in Table I of the filing.
The ESPP purchase price reflects a 15% discount to the average selling price of Curtiss-Wright common stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, Watts directly beneficially owns 3,583 shares of Curtiss-Wright common stock. The company notes that this ESPP transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c).
Curtiss-Wright Corporation executive reports share purchase under employee plan. Executive Vice President and COO Kevin M. Rayment acquired 10 shares of Curtiss-Wright common stock on 01/05/2026 through the company’s Employee Stock Purchase Plan (ESPP). The filing states the shares were bought at a price of $472.17 per share, determined with a 15% discount to the average selling price of the company’s common stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, Rayment beneficially owns 25,912 shares of Curtiss-Wright common stock, held directly.
Curtiss-Wright Corporation executive vice president and CFO K. Christopher Farkas reported a routine purchase of company stock under the employee stock purchase plan (ESPP). On 01/05/2026, he acquired 17 shares of Curtiss-Wright common stock at a price of $472.17 per share through the ESPP.
Following this transaction, he beneficially owns 4,253 shares of Curtiss-Wright common stock in direct ownership. The filing explains that under the ESPP, payroll deductions are made over a six-month offering period and used to buy shares at the end of the period, with the purchase price reflecting a 15% discount to the average selling price on 12/31/2025, the last day of that offering period.
Curtiss-Wright Corporation's Chair and CEO, who also serves as a director, reported a routine share purchase under the company’s Employee Stock Purchase Plan (ESPP). On 01/05/2026, the reporting person acquired 22 shares of common stock at a price of $472.17 per share through the ESPP, which uses payroll deductions collected over a six-month offering period.
Following this transaction, the reporting person directly owns 35,251 shares of Curtiss-Wright common stock. The filing notes that the ESPP transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c), reflecting a standard employee share purchase rather than a discretionary open-market trade.
Curtiss-Wright Corporation officer reports small stock sale under 10b5-1 plan
An officer of Curtiss-Wright Corporation (CW), serving as Vice President of Strategy & Business Development, reported selling 118 shares of common stock on 12/23/2025 at a price of $575 per share. After this transaction, the officer beneficially owns 3,570 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that was adopted on August 26, 2025 and is maintained by the officer's financial advisor. The filing notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those guidelines.
Curtiss-Wright Corp director Peter C. Wallace reported a charitable gift of 200 shares of the company’s common stock. The transaction took place on December 11, 2025 and is coded as a bona fide gift, with a reported price of $0 because no sale occurred.
The shares were donated to a donor advised fund that will use them for charitable purposes. After this donation, Wallace beneficially owns 5,007 shares of Curtiss-Wright common stock, held directly, and he has no beneficial interest, control, or dispositive power over the gifted shares or the donor advised fund.
Curtiss-Wright Corporation reported an insider stock transaction by its Chair and CEO, who is also a director. On 12/11/2025, the reporting person made a bona fide gift of 184 shares of common stock, reducing their directly held beneficial ownership to 35,229 shares. The shares were donated to a donor advised fund for charitable purposes.
According to the disclosure, the reporting person no longer has beneficial interest, control, or dispositive power over the gifted shares or the donor advised fund. The transaction was recorded as a gift with a price entry of zero, reflecting that there was no sale involved, only a transfer for charity.
Curtiss-Wright Corporation director reports stock gift
A director of Curtiss-Wright Corporation reported a bona fide gift of 2,000 shares of common stock on 12/11/2025. The shares were given to irrevocable trusts established for the benefit of the reporting person’s children. Neither the reporting person nor his spouse are trustees or beneficiaries of these trusts, and the reporting person has no beneficial or pecuniary interest in the trust assets.
Following this gift, the director directly holds 13,567.85 shares of Curtiss-Wright common stock. The transaction is coded as a gift and carries a price of $0, reflecting that it was a non-cash transfer for estate or family planning purposes rather than an open-market sale.
Curtiss-Wright Corporation insider transaction: A company officer, serving as Vice President of Strategy and Business Development, reported selling 175 shares of Curtiss-Wright common stock on 11/25/2025 at a price of $546.97 per share. After this sale, the reporting person beneficially owns 3,688 shares of Curtiss-Wright common stock.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that the reporting person adopted on August 26, 2025 and that is maintained by the reporting person’s financial advisor. The filing also notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those ownership requirements.
Curtiss-Wright (CW) has a Form 144 notice covering a planned sale of common stock under SEC Rule 144. The filing indicates that 688 shares of Curtiss-Wright common stock may be sold through Merrill, located at 6000 Fairview Rd., Suite 600, Charlotte, NC 28210, on the NYSE around 11/25/2025, with an aggregate market value of $391,472. The filing states that there were 36,847,638 shares of this class outstanding.
The shares to be sold were originally acquired from the company as stock-based compensation. One grant of common stock was acquired on 02/07/2024 as a stock bonus for 400 shares, and another on 03/18/2024 as a stock bonus for 288 shares, with both transactions described as stock bonus payments on their respective dates.